{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:59:15Z","timestamp":1791115155132,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,11,22]],"date-time":"2007-11-22T00:00:00Z","timestamp":1195689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,11,22]],"date-time":"2007-11-22T00:00:00Z","timestamp":1195689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1038\/sj.leu.2405043","type":"journal-article","created":{"date-parts":[[2007,11,22]],"date-time":"2007-11-22T12:53:35Z","timestamp":1195736015000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":165,"title":["Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F"],"prefix":"10.1038","volume":"22","author":[{"given":"K","family":"Shide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H K","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kumano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Karube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Oku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Katayose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kubuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hasuike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,22]]},"reference":[{"key":"BF2405043_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-L","volume":"74","author":"BA Witthuhn","year":"1993","unstructured":"Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993; 74: 227\u2013236.","journal-title":"Cell"},{"key":"BF2405043_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","volume":"93","author":"E Parganas","year":"1998","unstructured":"Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 1998; 93: 385\u2013395.","journal-title":"Cell"},{"key":"BF2405043_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/377591a0","volume":"377","author":"JN Ihle","year":"1995","unstructured":"Ihle JN . Cytokine receptor signalling. Nature 1995; 377: 591\u2013594.","journal-title":"Nature"},{"key":"BF2405043_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0092-8674(00)81277-5","volume":"84","author":"JN Ihle","year":"1996","unstructured":"Ihle JN . STATs: signal transducers and activators of transcription. Cell 1996; 84: 331\u2013334.","journal-title":"Cell"},{"issue":"Suppl 1","key":"BF2405043_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/stem.5530150814","volume":"15","author":"JN Ihle","year":"1997","unstructured":"Ihle JN, Nosaka T, Thierfelder W, Quelle FW, Shimoda K . Jaks and Stats in cytokine signaling. Stem Cells 1997; 15 (Suppl 1): 105\u2013111; discussion 112.","journal-title":"Stem Cells"},{"key":"BF2405043_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0092-8674(95)90234-1","volume":"83","author":"H Wu","year":"1995","unstructured":"Wu H, Liu X, Jaenisch R, Lodish HF . Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83: 59\u201367.","journal-title":"Cell"},{"key":"BF2405043_CR7","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.1128\/MCB.24.18.8037-8047.2004","volume":"24","author":"Y Cui","year":"2004","unstructured":"Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX et al. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 2004; 24: 8037\u20138047.","journal-title":"Mol Cell Biol"},{"key":"BF2405043_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054\u20131061.","journal-title":"Lancet"},{"key":"BF2405043_CR9","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144\u20131148.","journal-title":"Nature"},{"key":"BF2405043_CR10","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779\u20131790.","journal-title":"N Engl J Med"},{"key":"BF2405043_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7: 387\u2013397.","journal-title":"Cancer Cell"},{"key":"BF2405043_CR12","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","volume":"106","author":"AV Jones","year":"2005","unstructured":"Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106: 2162\u20132168.","journal-title":"Blood"},{"key":"BF2405043_CR13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.leukres.2006.08.018","volume":"31","author":"K Shide","year":"2007","unstructured":"Shide K, Shimoda K, Kamezaki K, Kakumitsu H, Kumano T, Numata A et al. Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence. Leuk Res 2007; 31: 1085\u20131092.","journal-title":"Leuk Res"},{"key":"BF2405043_CR14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","volume":"6","author":"W Dameshek","year":"1951","unstructured":"Dameshek W . Some speculations on the myeloproliferative syndromes. Blood 1951; 6: 372\u2013375.","journal-title":"Blood"},{"key":"BF2405043_CR15","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1182\/blood-2002-07-2341","volume":"101","author":"TL Reeder","year":"2003","unstructured":"Reeder TL, Bailey RJ, Dewald GW, Tefferi A . Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia. Blood 2003; 101: 1981\u20131983.","journal-title":"Blood"},{"key":"BF2405043_CR16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1182\/blood.V81.1.269.269","volume":"81","author":"JT Prchal","year":"1993","unstructured":"Prchal JT, Guan YL, Prchal JF, Barany F . Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis. Blood 1993; 81: 269\u2013271.","journal-title":"Blood"},{"key":"BF2405043_CR17","first-page":"1382","volume":"290","author":"JF Prchal","year":"1974","unstructured":"Prchal JF, Axelrad AA . Letter: Bone-marrow responses in polycythemia vera. N Engl J Med 1974; 290: 1382.","journal-title":"N Engl J Med"},{"key":"BF2405043_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0268-960X(87)90008-7","volume":"1","author":"CD Reid","year":"1987","unstructured":"Reid CD . The significance of endogenous erythroid colonies (EEC) in haematological disorders. Blood Rev 1987; 1: 133\u2013140.","journal-title":"Blood Rev"},{"key":"BF2405043_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","volume":"110","author":"A Tefferi","year":"2007","unstructured":"Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092\u20131097.","journal-title":"Blood"},{"key":"BF2405043_CR20","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","volume":"107","author":"G Wernig","year":"2006","unstructured":"Wernig G, Mercher T, Okabe R, Levine RL, Lee BH, Gilliland DG . Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood 2006; 107: 4274\u20134281.","journal-title":"Blood"},{"key":"BF2405043_CR21","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","volume":"108","author":"C Lacout","year":"2006","unstructured":"Lacout C, Pisani DF, Tulliez M, Gachelin FM, Vainchenker W, Villeval JL . JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Blood 2006; 108: 1652\u20131660.","journal-title":"Blood"},{"key":"BF2405043_CR22","doi-asserted-by":"publisher","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-06-2210","volume":"66","author":"TG Bumm","year":"2006","unstructured":"Bumm TG, Elsea C, Corbin AS, Loriaux M, Sherbenou D, Wood L et al. Characterization of murine JAK2V617F-positive myeloproliferative disease. Cancer Res 2006; 66: 11156\u201311165.","journal-title":"Cancer Res"},{"key":"BF2405043_CR23","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1371\/journal.pone.0000018","volume":"1","author":"VM Zaleskas","year":"2006","unstructured":"Zaleskas VM, Krause DS, Lazarides K, Patel N, Hu Y, Li S et al. Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F. PLoS ONE 2006; 1: e18.","journal-title":"PLoS ONE"},{"key":"BF2405043_CR24","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/blood.V91.7.2272","volume":"91","author":"J Domen","year":"1998","unstructured":"Domen J, Gandy KL, Weissman IL . Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 1998; 91: 2272\u20132282.","journal-title":"Blood"},{"key":"BF2405043_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.leukres.2004.12.009","volume":"29","author":"H Kakumitsu","year":"2005","unstructured":"Kakumitsu H, Kamezaki K, Shimoda K, Karube K, Haro T, Numata A et al. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis. Leuk Res 2005; 29: 761\u2013769.","journal-title":"Leuk Res"},{"key":"BF2405043_CR26","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1093\/nar\/18.10.2887","volume":"18","author":"J Riley","year":"1990","unstructured":"Riley J, Butler R, Ogilvie D, Finniear R, Jenner D, Powell S et al. A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res 1990; 18: 2887\u20132890.","journal-title":"Nucleic Acids Res"},{"key":"BF2405043_CR27","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1172\/JCI24225","volume":"115","author":"C Schessl","year":"2005","unstructured":"Schessl C, Rawat VP, Cusan M, Deshpande A, Kohl TM, Rosten PM et al. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J Clin Invest 2005; 115: 2159\u20132168.","journal-title":"J Clin Invest"},{"key":"BF2405043_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1538\/expanim.53.103","volume":"53","author":"A Noguchi","year":"2004","unstructured":"Noguchi A, Takekawa N, Einarsdottir T, Koura M, Noguchi Y, Takano K et al. Chromosomal mapping and zygosity check of transgenes based on flanking genome sequences determined by genomic walking. Exp Anim 2004; 53: 103\u2013111.","journal-title":"Exp Anim"},{"key":"BF2405043_CR29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.V90.2.597","volume":"90","author":"K Shimoda","year":"1997","unstructured":"Shimoda K, Feng J, Murakami H, Nagata S, Watling D, Rogers NC et al. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 1997; 90: 597\u2013604.","journal-title":"Blood"},{"key":"BF2405043_CR30","doi-asserted-by":"publisher","first-page":"18962","DOI":"10.1073\/pnas.0509714102","volume":"102","author":"X Lu","year":"2005","unstructured":"Lu X, Levine R, Tong W, Wernig G, Pikman Y, Zarnegar S et al. Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. Proc Natl Acad Sci USA 2005; 102: 18962\u201318967.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2405043_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1182\/blood-2005-11-009605","volume":"108","author":"R Kralovics","year":"2006","unstructured":"Kralovics R, Teo SS, Li S, Theocharides A, Buser AS, Tichelli A et al. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood 2006; 108: 1377\u20131380.","journal-title":"Blood"},{"key":"BF2405043_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/gcc.10297","volume":"39","author":"J Andrieux","year":"2004","unstructured":"Andrieux J, Demory JL, Dupriez B, Quief S, Plantier I, Roumier C et al. Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer 2004; 39: 82\u201387.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2405043_CR33","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0301-472X(03)00085-7","volume":"31","author":"E Komura","year":"2003","unstructured":"Komura E, Chagraoui H, Mansat de Mas V, Blanchet B, de Sepulveda P, Larbret F et al. Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression. Exp Hematol 2003; 31: 622\u2013630.","journal-title":"Exp Hematol"},{"key":"BF2405043_CR34","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1038\/sj.onc.1207510","volume":"23","author":"LC Jones","year":"2004","unstructured":"Jones LC, Tefferi A, Idos GE, Kumagai T, Hofmann WK, Koeffler HP . RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia. Oncogene 2004; 23: 7846\u20137853.","journal-title":"Oncogene"},{"key":"BF2405043_CR35","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1182\/blood-2002-04-1133","volume":"100","author":"H Chagraoui","year":"2002","unstructured":"Chagraoui H, Komura E, Tulliez M, Giraudier S, Vainchenker W, Wendling F . Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood 2002; 100: 3495\u20133503.","journal-title":"Blood"},{"key":"BF2405043_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08977199309029129","volume":"8","author":"AB Roberts","year":"1993","unstructured":"Roberts AB, Sporn MB . Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 1993; 8: 1\u20139.","journal-title":"Growth Factors"},{"key":"BF2405043_CR37","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1182\/blood-2002-09-2839","volume":"101","author":"H Chagraoui","year":"2003","unstructured":"Chagraoui H, Tulliez M, Smayra T, Komura E, Giraudier S, Yun T et al. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. Blood 2003; 101: 2983\u20132989.","journal-title":"Blood"},{"key":"BF2405043_CR38","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1182\/blood.V86.11.4025.bloodjournal86114025","volume":"86","author":"XQ Yan","year":"1995","unstructured":"Yan XQ, Lacey D, Fletcher F, Hartley C, McElroy P, Sun Y et al. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 1995; 86: 4025\u20134033.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2405043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405043","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:48:51Z","timestamp":1648781331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2405043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,22]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["BF2405043"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2405043","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,22]]},"assertion":[{"value":"28 August 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}